These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8104070

  • 1. Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Boiron JM, Marit G, Fabéres C, Cony-Makhoul P, Foures C, Ferrer AM, Cristol G, Sarrat A, Girault D, Reiffers J.
    Bone Marrow Transplant; 1993 Jul; 12(1):49-55. PubMed ID: 8104070
    [Abstract] [Full Text] [Related]

  • 2. Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma.
    Martínez E, Sureda A, Dalmases CD, Sánchez JA, Amill B, Tugues D, Sardá P, Miralles A, Brunet S, Domingo-Albós A, García J.
    Bone Marrow Transplant; 1996 Jul; 18(1):1-7. PubMed ID: 8831988
    [Abstract] [Full Text] [Related]

  • 3. Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.
    Alegre A, Tomás JF, Martínez-Chamorro C, Gil-Fernández JJ, Fernández-Villalta MJ, Arranz R, Díaz MA, Granda A, Bernardo MR, Escudero A, López-Lorenzo JL, Fernández-Rañada JM.
    Bone Marrow Transplant; 1997 Aug; 20(3):211-7. PubMed ID: 9257889
    [Abstract] [Full Text] [Related]

  • 4. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M, Sureda A, Martino R, Madoz P, García J, Brunet S.
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.
    Haas R, Hohaus S, Egerer G, Ehrhardt R, Witt B, Hunstein W.
    Bone Marrow Transplant; 1992 Jun; 9(6):459-65. PubMed ID: 1352717
    [Abstract] [Full Text] [Related]

  • 6. Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor: a phase I-II study.
    Mangan K, Mullaney M, Klumpp T, Goldberg S, Macdonald J.
    Stem Cells; 1993 Sep; 11(5):445-54. PubMed ID: 8241955
    [Abstract] [Full Text] [Related]

  • 7. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C, Carlo-Stella C, Regazzi E, Garau D, Sammarelli G, Caramatti C, Tabilio A, Mangoni L, Rizzoli V.
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [Abstract] [Full Text] [Related]

  • 8. Role of recombinant human granulocyte-macrophage colony stimulating factor for large scale collection of peripheral blood stem cells for autologous transplantation.
    Ravagnani F, Bregni M, Siena S, Sciorelli G, Gianni AM, Pellegris G.
    Haematologica; 1990 Mar; 75 Suppl 1():22-5. PubMed ID: 2190882
    [Abstract] [Full Text] [Related]

  • 9. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 11. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 12. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A, Donohue M, Liu L, Medina B, Corringham S, Ihasz A, Carrier E, Castro JE, Holman PR, Xu R, Law P, Ball ED, Lane TA.
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [Abstract] [Full Text] [Related]

  • 13. Changes in reticulocyte fractions during peripheral stem cell harvesting: role in monitoring stem cell collection.
    Remacha AF, Martino R, Sureda A, Sarda MP, Solá C, Tugues D, Amill B, Garcia J, Oliver A.
    Bone Marrow Transplant; 1996 Feb; 17(2):163-8. PubMed ID: 8640161
    [Abstract] [Full Text] [Related]

  • 14. Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma.
    Goldschmidt H, Hegenbart U, Haas R, Hunstein W.
    Bone Marrow Transplant; 1996 May; 17(5):691-7. PubMed ID: 8733683
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF).
    Siena S, Bregni M, Ravagnani F, Brando B, Tarella C, Bonadonna G, Gianni AM.
    Haematologica; 1990 May; 75 Suppl 1():6-10. PubMed ID: 2190884
    [Abstract] [Full Text] [Related]

  • 16. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors.
    Kotasek D, Shepherd KM, Sage RE, Dale BM, Norman JE, Charles P, Gregg A, Pillow A, Bolton A.
    Bone Marrow Transplant; 1992 Jan; 9(1):11-7. PubMed ID: 1347478
    [Abstract] [Full Text] [Related]

  • 17. Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma.
    Hiwase DK, Bollard G, Hiwase S, Bailey M, Muirhead J, Schwarer AP.
    Cytotherapy; 2007 Jan; 9(6):539-47. PubMed ID: 17882718
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
    Demirer T, Buckner CD, Gooley T, Appelbaum FR, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger WI.
    Bone Marrow Transplant; 1996 Jun; 17(6):937-41. PubMed ID: 8807097
    [Abstract] [Full Text] [Related]

  • 19. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
    Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, Onishi T, Abe T, Kawano Y, Kagami S, Takaue Y.
    Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
    [Abstract] [Full Text] [Related]

  • 20. Peripheral blood stem cell acquisition by large-volume leukapheresis in growth factor-stimulated and unstimulated rhesus monkeys: development of an animal model.
    Hillyer CD, Swenson RB, Hart KK, Lackey DA, Winton EF.
    Exp Hematol; 1993 Oct; 21(11):1455-9. PubMed ID: 8405225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.